Clinical Trial: Ponatinib in CML Patients in Chronic Phase
Study Status: Completed
Recruit Status: RECRUITING
Condition: Chronic Myeloid Leukemia, Chronic Phase
Study Type: OBSERVATIONAL
Official Title: Ponatinib in cHronic myelOid LEukemia patieNts In Chronic phaSe: the PHOENICS Protocol
Brief Summary:
The goal of this retrospective observational study is to evaluate any possible association between plasma concentrations of ponatinib and its pharmacodynamics (efficacy/tolerability) in patients affected by chronic myeloid leukemia in chronic phase (CML-CP).In particular, the aims of the study will be:primary aim: to investigate the relationships (if any) between plasma concentrations and activity/toxicity of ponatinib in a population of CML-CP patients enrolled in several Italian hematological…
Read more